Previous 10 | Next 10 |
Nes Ziona, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today announced that it will present the clinical development schedule for its Sepsis, COVID-19 and Solid Cancer programs d...
Biogen BIIB -28% after FDA advisory committee snub of Alzheimer’s drug.Quidel (QDEL) -26%.HighPoint Resources HPR -25% on Q3 earnings release.Co-Diagnostics CODX -24%.Enlivex Therapeutics (ENLV) -21%.Liquidia Technologies LQDA -20% on Q3 earnings...
Nes-Ziona, Israel, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today announced that the U.S. Patent and Trademark Office issued a notice of allowance for a new patent application covering me...
Enlivex Therapeutics ([[ENLV]]) announces that the Israeli Ministry of Health has signed off on a Phase 2b clinical trial evaluating Allocetra in sepsis patients.The randomized placebo-controlled study will recruit up to 160 participants in four cohorts.Allocetra is an immune-balancing cell t...
Nes Ziona, Israel, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today reported that the Israeli Ministry of Health authorized the initiation of a proposed Company-sponsored Phase IIb clinical...
* Findings and Analyses On 68,000 COVID-19 Patients Discussed in the Webinar on Thursday, November 5 th @ 10amET * Nes Ziona, Israel, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy compa...
The first two participants have been dosed in a 24-subject open-label Phase 2 clinical trial in Israel evaluating Enlivex Therapeutics' (ENLV) Allocetra plus standard-of-care treatment in severe and critically ill COVID-19 patients.The primary endpoint is safety. Secondary endpoints incl...
Nes Ziona, Israel, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today reported that the first two patients have been dosed in an investigator-initiated Phase II clinical trial evaluating ...
Kaixin Auto Holdings (KXIN) +57%.Midatech Pharma plc (MTP) +42% after announcing positive results from a Phase I study evaluating MTX110.Front Yard Residential (RESI) +34% after announcing going private deal valued at ~$2.4B.ARC Document Solutions (ARC) +26% on prelim...
The following slide deck was published by Enlivex Therapeutics Ltd. in conjunction with this event. For further details see: Enlivex (ENLV) Investor Presentation - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NASDAQ Market:
Enlivex Therapeutics Ltd. Website:
• First study of Allocetra TM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis 1 , and has limited treatment options Nes-Ziona, Israel, July 23, 2024 (GLOB...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...